ArticlePloS one2024

Preclinical safety assessment of modified gamma globin lentiviral vector-mediated autologous hematopoietic stem cell gene therapy for hemoglobinopathies.

Mohammad Shadid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.